>>

Alfano Massimo (ed.). Soluble Factors Mediating Innate Immune Responses to HIV Infection. Bentham Books,2010. — 159 p.. 2010

Human Immunodeficiency Virus (HIV) and AIDS pathogenesis have been under investigation for almost three decades. Substantial scientific and medical data have been collected on the structure of the virus and its replication cycle in infected cells. In addition, our understanding of the pathogenesis of HIV infection has greatly improved: It depends on virus-induced immune suppression as well as the formation of cellular virion reservoirs. The role of non-viral factors in AIDS pathogenesis was first identified 20 years ago with the description of soluble factors, the cytokines, which modulate HIV-1 replication in infected cells. Since then, more soluble factors have been discovered, capable of either stimulating or inhibiting HIV replication. Two critical anti-viral arms of HIV-specific CD8+ T cells (cytolytic and non-cytolytic) were shown to play a significant role in HIV prevention, and were associated with asymptomatic survival and slower disease progression. The activity of cytokines and their role in modulating HIV infection have been investigated in vitro and in vivo, both in animal models and human tissues such as gut and lymphoid tissue. Moreover, modalities of using cytokines as immunotherapy, either alone or in combination with anti-retrovirals, have been described. Leukocytes and epithelial cells produce defensins, which are innate effectors and immunomodulators during HIV infection, taking a variety of actions against microorganisms. They also act as immunomodulators involved in inflammation, tissue repair, and angiogenesis. Other soluble factors, such as the high mobility group box 1 (HMGB1) protein and urokinase plasminogen activator and its receptor (uPA/uPAR system), have a critical task between innate and adaptative immunity, and may possibly interfere with HIV-1 infection. Alpha 1-antitrypsin levels, which are deficient in HIV-1 disease, and rate-limiting for CD4+ T lymphocytes, could be a therapeutic target. Research for a better understanding of the role of vitamin D during HIV infection and disease progression to AIDS is ongoing. The complement system, a prominent component of the innate immunity, is likely to aid in the control of HIV replication, although the virus has developed escape mechanisms to avoid complement-mediated destruction.

| >>
CHAPTER 1 CD8 Antiviral Soluble Factors and Human Immunodeficiency Virus (HIV) Control
Nitin K. Saksena[*], Jing Qin Wu, Katherine Lau, Li Zhou, Maly Soedjono and Bin Wang
Retroviral Genetics Division, Center for Virus Research, Westmead Millennium Institute, The University of Sydney, Westmead NSW 2145.
CHAPTER 2 Cytokines and HIV Infection
Massimo Alfano1,* and Guido Poli1,2.
'.AIDS Immunopathogenesis Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy; 2Vita-Salute San Raffaele University, School of Medicine, Milan, Italy
CHAPTER 3 Defensins and HIV Infection
Theresa L. Chang and Mary Klotman[†]
Department of Medicine, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY.
CHAPTER 4 Extracellular HMGB1: an Ambiguous Messenger During HIV-1 Infection
Joel Gozlan1,2, Chloe Borde1 and Vincent Marechal1
1Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie - Paris 6, UMRS 872, Paris, F-75006 France; Universite Paris Descartes, UMRS 872, Paris, F-75006 France; INSERM, U872, Paris, F-75006 France; 2Laboratoire d
Virologie, Hopital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.
CHAPTER 5 The uPA/uPAR System and suPAR in HIV Infection
Sisse R. Ostrowski1, Eva Haastrup1, Anne Langkilde2, Henrik Ullum1 and Jesper Eugen-Olsen2
‘Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet and 2Clinical Research Centre 136, Copenhagen University Hospital, Hvidovre Hospital, Denmark.
CHAPTER 6 α1Antitrypsin Therapy Increases CD4+ Lymphocytes to Normal Values in HIV-1 Patients
Cynthia L. Bristow1,2, Jose Cortes3, Roya Mukhtarzad4, Maylis Trucy2, Aaron Franklin5, Val Romberg6, Ronald Winston2.
1Weill Medical College of Cornell University, New York, NY 10065; 2 Institutefor Human Genetics and Biochemistry, New York, NY 10065; 3Beth Israel Medical Center, New York, New York 10003; 4Kingsbrook Jewish Medical Center, Brooklyn, N
11203; 5University of Toledo College of Medicine, Toledo, OH 43614; 6CSL Behring, Bern, Switzerland CH3000.
CHAPTER 7 Vitamin D and HIV Infection
Joan Fibla1, and Antonio Caruz2
1Human Genetics Unit, Department of Basic Medical Sciences. Universitat de Lleida. IRB-LLEIDA. Montserrat Roig, 2 25199-Lleida, Catalonia, Spain and 2Immunogenetics Unit, Faculty of Sciences, Universidad de Jaen, Pasaje Las Lagunillas s/n 23071-Jaen, Spain.
CHAPTER 8 The Complement System and HIV-1 Infection
Heribert Stoiber, Zoltan Banki and Doris Wilflingseder[‡]
Department of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
More medical literature on Medic.Studio

Books and textbooks on the discipline Infectious diseases:

  1. Barbaro Giuseppe, Boccara Franc (eds.). Cardiovascular Disease in AIDS. 2nd edition. — Springer,2009. — 169 p. - 2009 ãîä
  2. Badley A.D. (ed.). Cell Death During HIV Infection. Taylor & Francis,2006. — 511 p. - 2006 ãîä
  3. Bartlett J.G., Finkbeiner A.K.. The Guide to Living with HIV Infection: Developed at the Johns Hopkins AIDS Clinic. Johns Hopkins University Press,2006. — 407 p. - 2006 ãîä
  4. Alder M.W.. ABC of AIDS. Fifth edition. —BMJ Publishing Group,2001. — 126 p. - 2001 ãîä